干细胞领域知识发现平台

论文名称	刊物与发表年
艾滋病功能性治愈研究的进展及挑战	中国艾滋病性病 2017
Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected Individuals	JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 2017
Impact of HIV Infection on Transplant Outcomes after Autologous Peripheral Blood Stem Cell Transplantation: A Retrospective Study of Japanese Registry Data	BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION PAGES 1596-1601 2018
应用脐血造血干细胞治疗艾滋病的研究进展	FOREIGN MEDICAL SCIENCES EPIDEMIOLOGY LEMOLOGY 2005
细胞治疗与AIDS功能性治愈	传染病信息 2015
Respiratory microsporidiosis caused by Enterocytozoon bieneusi in an HIV-negative hematopoietic stem cell transplant recipient	INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES 2018
Stem cell-based therapies for HIV/AIDS	IN BIOMEDICAL ENGINEERING APPROACHES FOR HIV/AIDS PROPHYLAXIS DIAGNOSTICS AND THERAPY ADVANCED DRUG DELIVERY REVIEWS 2016
B-101 Prospects and Strategies for an HIV Cure	JAIDS JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES 2014
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation	NATURE 2019
Safety of CD34+ Haematopoietic Stem Cells and CD4+ T Lymphocytes Transduced with LVsh5/C46 in HIV-1 infected PATIENTS with HIGH-RISK LYMPHOMA Author links open overlay panel	MOLECULAR THERAPY: METHODS & CLINICAL DEVELOPMENT 2019

论文名称

刊物与发表年

中国艾滋病性病
2017

Impact of Allogeneic Hematopoietic Stem Cell Transplantation on the HIV Reservoir and Immune Response in 3 HIV-Infected Individuals

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
2017

Impact of HIV Infection on Transplant Outcomes after Autologous Peripheral Blood Stem Cell Transplantation: A Retrospective Study of Japanese Registry Data

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION PAGES 1596-1601
2018

应用脐血造血干细胞治疗艾滋病的研究进展

FOREIGN MEDICAL SCIENCES EPIDEMIOLOGY LEMOLOGY
2005

细胞治疗与AIDS功能性治愈

传染病信息
2015

Respiratory microsporidiosis caused by Enterocytozoon bieneusi in an HIV-negative hematopoietic stem cell transplant recipient

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
2018

Stem cell-based therapies for HIV/AIDS

IN BIOMEDICAL ENGINEERING APPROACHES FOR HIV/AIDS PROPHYLAXIS DIAGNOSTICS AND THERAPY ADVANCED DRUG DELIVERY REVIEWS
2016

B-101 Prospects and Strategies for an HIV Cure

JAIDS JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
2014

HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation

NATURE
2019

Safety of CD34+ Haematopoietic Stem Cells and CD4+ T Lymphocytes Transduced with LVsh5/C46 in HIV-1 infected PATIENTS with HIGH-RISK LYMPHOMA Author links open overlay panel

MOLECULAR THERAPY: METHODS & CLINICAL DEVELOPMENT
2019

专利名称	专利公开号
Chimeric antigen receptor comprises truncated epidermal growth factor receptor variant III in hinge of Chimeric antigen receptor, and where Ev3 hinge links extracellular domain and one intracellular signaling domain	WO2019023396-A1
Treating subject in need of treatment for disease caused by a loss of function or activity of a protein, involves removing, reducing, depleting, inhibiting, inactivating or capturing adeno-associated virus binding antibodies	WO2019018439-A1
Engineered immune cell comprises first prodrug converting enzyme and/or a nucleic acid encoding prodrug converting enzyme, where first prodrug converting enzyme is expressed in cytoplasm of immune cell and is selected from carboxypeptidase	WO2019006467-A1
New engineered immune cell useful in ablation therapy for treating inflammation, autoimmune disease, or pathogenic infection in human, comprises prodrug converting enzyme or nucleic acid and receptor that binds to target antigen	WO2019006468-A1
Preparing stem cell active factor lyophilized powder useful for healing wound by detecting exogenous factor, isolating, identifying mesenchymal stem cell, preparing lyophilized powder, detecting activity factor and filling solvent	CN108753708-A
Composition for enhancing an immune response against an antigen in a subject, comprises an anti-cytotoxic T-lymphocyte associated antigen 4 (CTLA4) antibody, and a synthetic antigen capable of generating an immune response in the subject	WO2018204760-A1
Engineering Mesenchymal Stem Cells Using Homologous Recombination	WO_2016_077273_A1

专利名称

专利公开号

Chimeric antigen receptor comprises truncated epidermal growth factor receptor variant III in hinge of Chimeric antigen receptor, and where Ev3 hinge links extracellular domain and one intracellular signaling domain

WO2019023396-A1

Treating subject in need of treatment for disease caused by a loss of function or activity of a protein, involves removing, reducing, depleting, inhibiting, inactivating or capturing adeno-associated virus binding antibodies

WO2019018439-A1

Engineered immune cell comprises first prodrug converting enzyme and/or a nucleic acid encoding prodrug converting enzyme, where first prodrug converting enzyme is expressed in cytoplasm of immune cell and is selected from carboxypeptidase

WO2019006467-A1

New engineered immune cell useful in ablation therapy for treating inflammation, autoimmune disease, or pathogenic infection in human, comprises prodrug converting enzyme or nucleic acid and receptor that binds to target antigen

WO2019006468-A1

Preparing stem cell active factor lyophilized powder useful for healing wound by detecting exogenous factor, isolating, identifying mesenchymal stem cell, preparing lyophilized powder, detecting activity factor and filling solvent

CN108753708-A